Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Professor Camille Carroll
Newcastle Authors
Title
Year
Full text
Professor Camille Carroll
Professor Edward Meinert
Digital health technologies and self-efficacy in Parkinson's: a scoping review
2025
Professor Camille Carroll
Exenatide once a week versus placebo as a potential disease modifying treatment for people with Parkinson’s disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
2025
Professor Camille Carroll
Improving recruitment and retention of people with Parkinson's disease to clinical studies: A scoping review
2025
Dr Alex Grundmann
Professor Camille Carroll
Dr Dexter Canoy
Dr Precious Onyeachu
Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland
2025
Professor Camille Carroll
Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial
2025
Professor Camille Carroll
Professor David Burn
Professor Nicola Pavese
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies
2025
Professor Camille Carroll
A programme evaluation of 'First Steps': A peer-conceived, developed and led self-management intervention for people after a Parkinson's diagnosis
2024
Professor Camille Carroll
Professor Lynn Rochester
Accelerating Parkinson’s Disease drug development with federated learning approaches
2024
Professor Camille Carroll
Addressing Comorbidities in People with Parkinson's Disease: Considerations From An Expert Panel
2024
Professor Camille Carroll
Advantages and Challenges of Platform Trials for Disease Modifying Therapies in Parkinson's Disease
2024
Professor Lynn Rochester
Dr Marie-Louise Zeissler
Professor Camille Carroll
Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials
2024
Professor Alison Yarnall
Professor Camille Carroll
Improving conversations about Parkinson’s dementia
2024
Professor Camille Carroll
Is SH3GL2 p.G276V the Causal Functional Variant Underlying Parkinson's Disease Risk at this Locus?
2024
Professor Camille Carroll
Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease
2024
Dr Marie-Louise Zeissler
Sally Collins
Professor Camille Carroll
Patient and Public Involvement and Engagement in the Development of a Platform Clinical Trial for Parkinson's Disease: An Evaluation Protocol
2024
1
2
3
4